Carmell Therapeutics's total assets for Q were $2.44M, a decrease of -51.49% from the previous quarter. CTCX total liabilities were $6.51M for the fiscal quarter, a 1.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.